Adjuvant Therapies for Patients With HCC and MVI

Clinical trial NCT02436902 · UNKNOWN

Trial details

NCT number: NCT02436902
Sponsor: Guangxi Medical University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-02-01
Primary completion: 2022-08-23
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.